Respiratory
4 drugs are in development for Healthy Volunteer.
- Companies
- 4
- Clinical trials
- 55
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Healthy Volunteer pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| BIIB080 | BIOGEN INC. (BIIB) |
Phase 1(2)
| Drug | Company |
|---|---|
| A-005 | ALUMIS INC. (ALMS) |
| varegacestat | Immunome Inc. (IMNM) |
Phase 4(1)
| Drug | Company |
|---|---|
| Upadacitinib | AbbVie Inc. (ABBV) |
About this indication
Healthy Volunteer context
Respiratory·MeSH: Influenza, Human (D007251)
Narrower concept of MeSH descriptor Influenza
Compare drugs
Frequently asked questions
How many drugs are in development for Healthy Volunteer?
BioSniper tracks 4 drugs in development for Healthy Volunteer across 4 companies.
How many clinical trials target Healthy Volunteer?
There are 55 clinical trials targeting Healthy Volunteer tracked by BioSniper.